NCT00142181 Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00142168 CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia Status TERMINATED Phase PHASE2
NCT00142116 Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00140478 Mifepristone (RU-486) in Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00140244 Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome Status COMPLETED Phase PHASE2
NCT00140231 Role of Leptin in the Neuroendocrine and Immune Response to Fasting Status COMPLETED Phase PHASE1/PHASE2
NCT00139243 Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase PHASE1/PHASE2
NCT00139204 Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients Status COMPLETED Phase NA
NCT00139191 Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer Status COMPLETED Phase NA
NCT00137839 Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung Status COMPLETED Phase PHASE2
NCT00137774 Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT00137761 Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00136539 Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer Status COMPLETED Phase PHASE2
NCT00136487 Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00136214 Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects Status COMPLETED Phase N/A